- NCT00051194
A 6-week Safety & Efficacy Study of Combination Intraocular Pressure-lowering Therapy in Patients With Open-angle Glaucoma or Ocular Hypertension
Phase 2Completed - NCT00051116
A Phase II Study of Continuous Versus Syncopated Dosing of CC-5013 for the Treatment of Refractory Multiple Myeloma
Phase 2Completed - NCT00051181
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma
Phase 3Completed - NCT00051090
Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIV
Not ApplicableWithdrawn - NCT00051103
Oral Drug Study In Women With Refractory Metastatic Breast Cancer After First-line or Second-line Herceptin.
Phase 2Completed - NCT00051077
Treatment of Hepatitis in Patients Who Are Triple-Infected With HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV)
Phase 2Withdrawn - NCT00051051
A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer
Phase 2Completed - NCT00050973
Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer
Phase 3Completed - NCT00051025
Phase II Study of ONTAK in Previously Treated Patients With Low-grade Non-Hodgkin's Lymphoma (NHL)
Phase 2Completed - NCT00051012
Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients
Phase 4Completed - NCT00050999
Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients
Phase 4Completed - NCT00050986
Phase I/II Evaluation of Temozolomide and ZARNESTRA (R115777) for Recurrent and Progressive Glioblastoma Multiforme
Phase 1Completed - NCT00050960
Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer
Phase 3Completed - NCT00051038
Study of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected Patients
Phase 2Completed - NCT00050947
Pediatric Epilepsy Study
Phase 3Completed - NCT00050921
Administration of Growth Hormone to Increase CD4+ Count in Patients Taking Anti-HIV Drugs
Not ApplicableCompleted - NCT00050895
Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients
Phase 3Completed - NCT00050934
Pediatric Epilepsy Study
Phase 3Completed - NCT00050908
Blood Vessel Function in HIV-Infected Patients Taking Anti-HIV Drugs
Completed - NCT00050882
Safety and Effectiveness of an Investigational Agent (GM-611) in Patients With Diabetic Gastroparesis
Phase 2Completed - NCT00050869
Learning a Motor Task Through Observation
Completed - NCT00050856
Fuzeon (Enfuvirtide) Early Access Program for Patients With HIV-1 Infection
Phase 3Completed - NCT00050843
A Study to Access the Safety/Efficacy of Thalidomide in the Treatment of Anemia in Patients With Myelodysplastic Syndromes
Phase 3Completed - NCT00050830
A Phase 2, Randomized, Open-Label Study Of Single Agent CI-1033 In Patients With Advanced Non-Small Cell Lung Cancer
Phase 2Completed - NCT00050817
Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)
Phase 3Completed - NCT00050778
A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis
Phase 2Completed - NCT00050791
Effects of Leptin Treatment on Weight Loss
Phase 2Completed - NCT00050804
Evaluation of Stress Disorders
Phase 4Completed - NCT00050765
Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial Injection
Phase 1Unknown - NCT00050687
Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies
Phase 1Terminated - NCT00050700
Brain Imaging in Depression
Completed - NCT00050713
Sirolimus Therapy for Idiopathic and Lupus Membranous Nephropathy
Phase 2Completed - NCT00050752
Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer
Recruiting - NCT00050635
STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea
Phase 4Completed - NCT00050674
Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung Carcinoma
Phase 2Completed - NCT00050609
Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach Emptying
Phase 2Completed - NCT00050427
A Study of ET-743 (Trabectedin) in Patients With Advanced Breast Cancer
Phase 2Completed - NCT00050661
To Study the Use of Humanized CD25 in Preventing the Relapse of Psoriasis Vulgaris
Phase 1Completed - NCT00050648
To Study the Effects of CD25 and Low Dose Cyclosporin in the Treatment of Active Psoriasis Vulgaris
Phase 1Completed - NCT00050726
Studies of Influenza Vaccine and Tetanus-Pneumococcal Vaccine in HIV-infected Patients Receiving Interleukin-2
Phase 2Completed - NCT00050570
Reducing Eating Disorder Risk Factors
Not ApplicableCompleted - NCT00050596
Comparison Study of MDX-010 (CTLA-4) Alone and Combined With Docetaxel in the Treatment of Patients With Hormone Refractory Prostate Cancer
Phase 2Completed - NCT00050622
Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
Not ApplicableCompleted - NCT00050583
Treatment of Medically Unexplained Physical Ailments (Somatization Disorder)
Phase 3Completed - NCT00050557
Family Psychoeducation for Children With Mood Disorders
Phase 1Completed - NCT00050518
APSV in Vaccinia Naive Adults
Phase 2Completed - NCT00050505
Expanded Dryvax Dilution Study in Previously Vaccinated Adults
Phase 2Completed - NCT00004557
Models of Disordered Knowledge and Memory Systems in Dementia and Related Disorders
Completed - NCT00004576
Study of LY300164 for the Treatment of Parkinson's Disease
Phase 2Completed - NCT00001752
Vascular and Metabolic Effects of Hormone Therapy Combined With L-Arginine in Postmenopausal Women
Phase 2Completed - NCT00001753
Study of the Effects of Temperature on Metabolism in Human Muscle
Phase 1Completed - NCT00050401
Ventilator-Associated Pneumonia/Hospital-Acquired Pneumonia Requiring Mechanical Ventilatory Support
Phase 3Completed - NCT00050414
A Study of Trabectedin in Patients With Advanced Ovarian Cancer
Phase 2Completed - NCT00050440
Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial Carcinoma
Phase 2Completed - NCT00050466
Dynamic Light Scattering and Keratoscopy for Corneal Examination
Completed - NCT00005781
Assessment of Digital Imaging as a Tool for Diagnosing Psoriasis, Hand Rashes and Unusual Moles
Completed - NCT00005783
A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling Disorders
Phase 1Completed - NCT00001705
Immunization of Patients With Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence
Phase 2Completed - NCT00004574
Vitamin Replacement in Abetalipoproteinemia
Completed - NCT00050492
Biological Markers in Retinal Vasculitis
Completed - NCT00050479
Laser and Medical Treatment of Diabetic Macular Edema
Phase 3Completed - NCT00005912
Voriconazole to Prevent Systemic Fungal Infections in Children
Phase 1Completed - NCT00005570
An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers
Completed - NCT00005574
Gentamicin Treatment of Muscular Dystrophy
Phase 1Completed - NCT00001384
A Pilot Trial of AC (Adriamycin, Cyclophosphamide) Chemotherapy With G-CSF (Granulocyte Colony-Stimulating Factor) Followed by Infusional Taxol (Paclitaxel) as Adjuvant Treatment for High Risk Stage II and Stage III Breast Cancer Patients
Phase 2Completed - NCT00001839
A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome
Phase 2Completed - NCT00001768
Treatment of Childhood Onset Psychiatric Disorders With Intravenous Immunoglobulin (IVIg)
Phase 3Completed - NCT00006395
Drug Interaction Study of Tegretol (Carbamazepine) and St. John's Wort in Normal Volunteers
Phase 4Completed - NCT00006191
Effect of Levetiracetam on Brain Excitability
Completed - NCT00006071
Effects of Rosiglitazone on Blood Vessels in Patients With High Blood Pressure and High Cholesterol
Completed - NCT00006155
SU5416 and Carboplatin to Treat Ovarian Cancer
Phase 1Completed - NCT00001421
Methimazole to Treat Polymyositis and Dermatomyositis
Phase 2Completed - NCT00001402
PET Scan to Determine Areas of Blood Flow and Activity in the Hearts of Patients With Heart Disease Taking Beta-Blockers
Phase 2Completed - NCT00001805
A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by Rituximab
Phase 2Completed - NCT00001449
A Phase I Study of Weekly Gemcitabine in Combination With Infusional Fluorodeoxyuridine and Oral Calcium Leucovorin in Adult Cancer Patients
Phase 1Completed - NCT00001189
The Treatment of Grade I Sarcomas and Benign, Non-Metastasizing Highly Invasive Soft Tissue Tumors
Phase 2Completed - NCT00001587
A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver
Phase 1Completed - NCT00001669
A 48-Week (24-Week Baseline Followed by a 24-Week Treatment) Phase II Pilot Study of the Tolerability and Effect/Efficacy of Subcutaneously Administered Insulin-Like Growth Factor-1 (rhIGF) (CEP-151) in Multiple Sclerosis (MS) Patients
Phase 2Completed - NCT00001668
Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors
Completed - NCT00001667
Genotype/Phenotype Correlation of Movement Disorders and Other Neurological Diseases
Completed - NCT00001665
Transcranial Magnetic Stimulation for the Treatment of Parkinson's Disease
Completed - NCT00001450
Phase II Trial of a 96-Hour Continuous Infusion of Paclitaxel Followed by Cisplatin for Patients With Stage III/IV and Relapsed NSCLC
Phase 2Completed - NCT00001658
Amoxicillin for the Treatment of Pediatric Autoimmune Disorders Associated With Streptococcal Infections
Phase 4Completed - NCT00001657
Use of Repetitive Transcranial Magnetic Stimulation (rTMS) in Chronic Posttraumatic Stress Disorder (PTSD)
Completed - NCT00001455
Iron Overload in African Americans
Completed - NCT00001646
Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis
Phase 3Completed - NCT00001642
Positional Cloning of the Gene(s) Responsible for Alagille Syndrome
Completed - NCT00001639
Evaluation of Patients With Unresolved Chromosome Abnormalities
Completed - NCT00001633
Safety and Effectiveness of Coronary Magnetic Resonance Angiography (CMRA) Imaging
Phase 2Completed - NCT00001629
The Role of Angiotensin Type I Receptor in the Regulation of Human Coronary Vascular Function
Phase 3Completed - NCT00001628
The Role of Angiotensin Type I Receptor in the Regulation of Human Peripheral Vascular Function
Phase 3Completed - NCT00001624
Effect of Insulin on Endothelin-Dependent Vascular Tone in the Forearm Circulation
Phase 1Completed - NCT00001622
Study of the Response of Human Small Blood Vessels
Phase 1Completed - NCT00001459
Analysis of Heart Muscle Function in Patients With Heart Disease and Normal Volunteers
Completed - NCT00001617
Test of QLS Device to Detect Early Cataracts
Completed - NCT00001615
Phase I Study of Corticosteroid Treatment of Ill-Defined Choroidal Neovascularization in Age-Related Macular Degeneration
Phase 1Completed - NCT00001614
The Safety and Efficacy of Chicken Type II Collagen on Uveitis Associated With Juvenile Rheumatoid Arthritis
Phase 1Completed - NCT00001612
Long-Term Follow-Up of Patients Enrolled in the Early Treatment Diabetic Retinopathy Study (ETDRS)
Completed - NCT00001461
Study of the Interaction Between the Cells Lining Blood Vessels and Angiotensin-Converting Enzyme
Completed - NCT00001605
Vaccination for Middle Ear Infection
Phase 1Completed